KL-VS heterozygosity is associated with reduced tau accumulation and lower memory impairment in Alzheimer’s disease
View ORCID ProfileJulia Neitzel, Nicolai Franzmeier, Anna Rubinski, Martin Dichgans, Matthias Brendel, Rainer Malik, Michael Ewers, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
doi: https://doi.org/10.1101/2020.07.29.20164434
Julia Neitzel
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
PhDNicolai Franzmeier
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
PhDAnna Rubinski
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
MScMartin Dichgans
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
2German Center of Neurodegenerative Diseases (DZNE), Munich
3SyNergy Cluster Munich
MDMatthias Brendel
4Department of Nuclear Medicine, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
MDRainer Malik
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
PhDMichael Ewers
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany
2German Center of Neurodegenerative Diseases (DZNE), Munich
PhDArticle usage
Posted July 31, 2020.
KL-VS heterozygosity is associated with reduced tau accumulation and lower memory impairment in Alzheimer’s disease
Julia Neitzel, Nicolai Franzmeier, Anna Rubinski, Martin Dichgans, Matthias Brendel, Rainer Malik, Michael Ewers, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
medRxiv 2020.07.29.20164434; doi: https://doi.org/10.1101/2020.07.29.20164434
KL-VS heterozygosity is associated with reduced tau accumulation and lower memory impairment in Alzheimer’s disease
Julia Neitzel, Nicolai Franzmeier, Anna Rubinski, Martin Dichgans, Matthias Brendel, Rainer Malik, Michael Ewers, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
medRxiv 2020.07.29.20164434; doi: https://doi.org/10.1101/2020.07.29.20164434
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)